AFC-TAB-760

antibody from Creative Biolabs

Targeting: FCER2 CD23, CD23A, CLEC4J, FCE2

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Flow cytometry (Recommended by provider)

Blocking/Neutralizing (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

AFC-TAB-760

Provider

Creative Biolabs

Product name

Afuco? Anti-CD23 ADCC Recombinant Antibody (Lumiliximab), ADCC Enhanced

Antibody type

Monoclonal

Description

This product is an ADCC enhanced antibody produced by our Afuco? platform. Recombinant chimeric (primate/human) antibody expressed in CHO. Lumiliximab is a monoclonal antibody that targets CD23. It acts as an immunomodulator. The drug is a chimeric antibody from Macaca irus and Homo sapiens.

Reactivity

Human

Host

Simian

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

Lumiliximab

Storage

Store at +4¡ãC short term (1-2 weeks). Aliquot and store at -20¡ãC long term. Avoid repeated freeze/thaw cycles.